These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells. Crawford KW, Bittman R, Chun J, Byun HS, Bowen WD. Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383 [Abstract] [Full Text] [Related]
3. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. Antoon JW, Liu J, Gestaut MM, Burow ME, Beckman BS, Foroozesh M. J Med Chem; 2009 Sep 24; 52(18):5748-52. PubMed ID: 19694470 [Abstract] [Full Text] [Related]
4. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth. Flowers M, Fabriás G, Delgado A, Casas J, Abad JL, Cabot MC. Breast Cancer Res Treat; 2012 Jun 24; 133(2):447-58. PubMed ID: 21935601 [Abstract] [Full Text] [Related]
5. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics. Antoon JW, Liu J, Ponnapakkam AP, Gestaut MM, Foroozesh M, Beckman BS. Cancer Chemother Pharmacol; 2010 May 24; 65(6):1191-5. PubMed ID: 20155475 [Abstract] [Full Text] [Related]
6. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Awad AB, Barta SL, Fink CS, Bradford PG. Mol Nutr Food Res; 2008 Apr 24; 52(4):419-26. PubMed ID: 18338406 [Abstract] [Full Text] [Related]
7. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Furlong SJ, Mader JS, Hoskin DW. Oncol Rep; 2006 May 24; 15(5):1385-90. PubMed ID: 16596215 [Abstract] [Full Text] [Related]
8. Tailoring structure-function and targeting properties of ceramides by site-specific cationization. Szulc ZM, Bielawski J, Gracz H, Gustilo M, Mayroo N, Hannun YA, Obeid LM, Bielawska A. Bioorg Med Chem; 2006 Nov 01; 14(21):7083-104. PubMed ID: 16919460 [Abstract] [Full Text] [Related]
9. Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells. Kimura K, Markowski M, Edsall LC, Spiegel S, Gelmann EP. Cell Death Differ; 2003 Feb 01; 10(2):240-8. PubMed ID: 12700652 [Abstract] [Full Text] [Related]
10. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell. Veluthakal R, Palanivel R, Zhao Y, McDonald P, Gruber S, Kowluru A. Apoptosis; 2005 Aug 01; 10(4):841-50. PubMed ID: 16133874 [Abstract] [Full Text] [Related]
11. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Schmelz K, Wieder T, Tamm I, Müller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dörken B, Daniel PT. Oncogene; 2004 Sep 02; 23(40):6743-59. PubMed ID: 15273737 [Abstract] [Full Text] [Related]
12. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Int J Oncol; 2004 Jun 02; 24(6):1473-80. PubMed ID: 15138590 [Abstract] [Full Text] [Related]
13. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Batra S, Reynolds CP, Maurer BJ. Cancer Res; 2004 Aug 01; 64(15):5415-24. PubMed ID: 15289350 [Abstract] [Full Text] [Related]
14. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. Liu YY, Han TY, Giuliano AE, Ichikawa S, Hirabayashi Y, Cabot MC. Exp Cell Res; 1999 Nov 01; 252(2):464-70. PubMed ID: 10527636 [Abstract] [Full Text] [Related]
15. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. Chintalapati M, Truax R, Stout R, Portier R, Losso JN. J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359 [Abstract] [Full Text] [Related]
16. Induction of apoptotic cell death by a ceramide analog in PC-3 prostate cancer cells. Oh JE, So KS, Lim SJ, Kim MY. Arch Pharm Res; 2006 Dec 24; 29(12):1140-6. PubMed ID: 17225464 [Abstract] [Full Text] [Related]
17. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ. Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439 [Abstract] [Full Text] [Related]
18. Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells. Ostrakhovitch EA, Cherian MG. Apoptosis; 2005 Jan 01; 10(1):111-21. PubMed ID: 15711927 [Abstract] [Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
20. Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species. Chan SY, Hilchie AL, Brown MG, Anderson R, Hoskin DW. Exp Mol Pathol; 2007 Feb 01; 82(1):1-11. PubMed ID: 16624283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]